Rita Assi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL (NCT06484920) | Rita Assi | 2024-11-18 |
Track Rita Assi automatically
Every clearance here is in the API, with alerts when new ones post.